Acute rheumatic fever: A chink in the chain that links the heart to the throat?

Lancet Infectious Diseases

Volumn 4, Issue 4, 2004, Pages 240-245

  McDonald, Malcolm ^a,b   Currie, Bart J ^a,b   Carapetis, Jonathan R ^c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CLINICAL FEATURE; HUMAN; PATHOGENESIS; PHARYNGITIS; PRIORITY JOURNAL; PYODERMA; REVIEW; RHEUMATIC FEVER; SKIN INFECTION; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G;

EID: 1642420500     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)00975-2     Document Type: Note

References (82)

1. Quinn R. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis. 11:1989;928-953.
2. Markowitz M. The decline of rheumatic fever: role of medical intervention. J Pediatr. 106:1985;545-550.
3. Bisno A., Shulman S., Dajani A. The rise and fall (and rise?) of rheumatic fever. JAMA. 259:1988;728-729.
4. Mendez G.F., Cowie M.R. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol. 80:2001;213-219.
5. Steer A.C., Carapetis J.R., Nolan T.M., Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health. 38:2002;229-234.
6. Saxena A. Rheumatic fever and long-term sequelae in children. Curr Treat Options Cardiovasc Med. 4:2002;309-319.
7. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum. 16:1995;47-51.
8. Wannamaker L. The chain that links the heart to the throat. Circulation. 48:1973;9-18.
9. Carapetis J.R., Wolff D.R., Currie B.J. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med J Aust. 164:1996;146-149.
10. Carapetis J.R., Currie B.J. Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia. Adv Exp Med Biol. 418:1997;233-236.
11. Nimmo G., Tinniswood R., Nuttall N., Baker G., McDonald B. Group A streptococcal infection in an Aboriginal community. Med J Aust. 157:1992;521-522.
12. Carapetis J.R., Currie B.J., Kaplan E.L. Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century. Clin Infect Dis. 28:1999;205-210.
13. Rammelkamp C., Breese B., Griffeath H. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Mod Concepts Cardiovasc Dis. 25:1956;365-369.
14. Denny FW J. A 45-year perspective on the streptococcus and rheumatic fever: the Edward H Kass lecture in infectious disease history. Clin Infect Dis. 19:1994;1110-1112.
15. Wannamaker L. Differences between streptococcal infections of the throat and of the skin. (Second of two parts). N Engl J Med. 282:1970;78-85.
16. Bisno A.L., Pearce I.A., Wall H.P., Moody M.D., Stollerman G.H. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis. N Engl J Med. 283:1970;561-565.
17. Kaplan E., Anthony B., Chapman S., Ayoub E., Wannamaker L. The influence of site of infection on the immune response to group A streptococci. J Clin Invest. 49:1970;1405-1414.
18. Stollerman G.H. Rheumatic fever in the 21st century. Clin Infect Dis. 33:2001;806-814.
19. Dillon H.C., Derrick C.W., Dillon M.S. M-antigens common to pyoderma and acute glomerulonephritis. J Infect Dis. 130:1974;257-267.
20. Widdowson J.P., Maxted W.R., Pinney A.M. An M-associated protein antigen (MAP) of group A streptococci. J Hyg (Lond). 69:1971;553-564.
21. Maxted W.R., Widdowson J.P., Fraser C.A.M., Ball L.C., Bassett D. The use of serum opacity reaction in the typing of group A streptococci. J Med Microbiol. 6:1973;83-90.
22. Molina A.M., Coratza G., Musmanno R.A., Figura N., Rossolini G.M. Production of serum-opacity factor by Streptococcus pyogenes strains isolated from pharyngitis in children. Prevalence of "rheumatogenic" M types among OF-negative strains. Eur J Epidemiol. 1:1985;37-41.
23. Bessen D., Jones K., Fischetti V. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med. 169:1989;269-283.
24. Bessen D., Fischetti V. Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exper Med. 172:1990;1757-1764.
25. Bessen D., Veasy L., Hill H., Augustine N., Fischetti V. Serologic evidence for a Class 1 group A streptococcal infection among rheumatic fever patients. J Infect Dis. 172:1995;1608-1611.
26. Bessen D., Sotir C., Readdy T., Hollingshead S. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis. 173:1996;896-900.
27. Potter E., Svartman M., Mohammed I., Cox R., Poon-King T., Earle D. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. J Pediatr. 92:1978;325-333.
28. Anthony B., Kaplan E., Wannamaker L., Chapman S. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Am J Epidemiol. 104:1976;652-666.
29. Bisno A., Pearce I., Stollerman G. Streptococcal infections that fail to cause recurrences of rheumatic fever. J Infect Dis. 136:1977;278-285.
30. Popat K., Riding W. Acute rheumatic fever following streptococcal wound infection. Postgrad Med J. 52:1976;165-170.
31. Kelly A. Top End rheumatic heart disease program: a report to the Commonwealth, February-November 2002. NT Dis Control Bull 2003; 10: 9-11.
32. Carapetis J.R., Currie B.J., Mathews J.D. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population. Epidemiol Infect. 124:2000;239-244.
33. Carapetis J.R., Currie B.J. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. 23:1999;159-163.
34. Brown A, Purton L, Schaeffer G, Wheaton G, White A. Central Australian Rheumatic Heart Disease Control Program: A report to the Commonwealth, November 2002. NT Dis Control Bull 2003; 10: 1-8.
35. Neilson G., Streatfield R., West M., Johnson S., Glavin W., Baird S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah Aboriginal community, north Queensland: establishment of a prophylactic program. Med J Aust. 158:1993;316-318.
36. Richmond P., Harris L. Rheumatic fever in the Kimberley region of Western Australia. J Trop Pediatr. 44:1998;148-152.
37. Currie B.J., Brewster D.R. Rheumatic fever in Aboriginal children. J Paediatr Child Health. 38:2002;223-225.
38. Currie B.J., Carapetis J.R. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol. 41:2000;139-143.
39. Gardiner D., Sriprakash K. Molecular epidemiology of impetiginous group A streptococcal infections in Aboriginal communities of northern Australia. J Clin Microbiol. 34:1996;1448-1452.
40. Evans C. Acute post streptococcal glomerulonephritis in the Northern Territory 1980-2000. NT Dis Control Bull. 8:2001;1-5.
41. Kearns T., Evans C., Krause V. Outbreak of acute post streptococcal glomerulonephritis in the Northern Territory-2000. NT Dis Control Bull. 8:2001;6-13.
42. Carapetis J., Gardiner D., Currie B., Mathews J.D. Multiple strains of Streptococcus pyogenes in skin sores of Aboriginal Australians. J Clin Microbiol. 33:1995;1471-1472.
43. Van Buynder P., Gaggin J., Martin D., Pugsley D., Mathews J. Streptococcal infection and renal disease markers in Australian Aboriginal children. Med J Aust. 156:1992;537-540.
44. Carapetis J., Connors C., Yarmirr D., Krause V., Currie B. Success of a scabies control program in an Australian Aboriginal community. Pediatr Infect Dis J. 16:1997;494-499.
45. Poon-King T., Mayon-White R., Harnaryan C., et al. Rheumatic fever and glomerulonephritis. Parker M.T. Pathogenic streptococci: proceedings of the 7th international symposium on streptococci and streptococcal diseases. 1979;Reedbooks, Surrey.
46. Maxted W. Disease association and geographical distribution of the M types of group A streptococci. Read S.E., Zabriskie J.B. Streptococcal diseases and the immune response. 1980;Academic Press, New York.
47. Martin D.R., Voss L.M., Walker S.J., Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J. 13:1994;264-269.
48. Carapetis JR. PhD thesis: Ending the heartache: the epidemiology and control of acute rheumatic fever and rheumatic heart disease in the Top End of the Northern Territory. Sydney: University of Sydney, 1998.
49. Majeed H.A., Khuffash F.A., Yousof A.M., et al. The rheumatogenic and nephritogenic strains of the group A streptococcus: the Kuwait experience. N Z Med J. 101:1988;398-401.
50. Carapetis J.R., Currie B.J. Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever. Arch Dis Child. 85:2001;223-227.
51. Majeed H., Khuffash F., Sharda D., Farwana S., El-Sherbiny A., Ghafour S. Children with acute rheumatic fever and acute poststreptococcal glomerulonephritis and their families in a subtropical zone: a three-year prospective comparative epidemiological study. Int J Epidemiol. 16:1987;561-568.
52. Potter E.V., Svartman M., Burt E.G., Finklea J.F., Poon-King T., Earle D.P. Relationship of acute rheumatic fever to acute glomerulonephritis in Trinidad. J Infect Dis. 125:1972;619-625.
53. da Silva C.H. Rheumatic fever: a multicenter study in the state of Sao Paulo. Rev Hosp Clin Fac Med Sao Paulo. 54:1999;85-90.
54. Martin D., Sriprakash K. Epidemiology of group A streptococcal disease in Australia and New Zealand. Asche V. Recent advances in microbiology. 1997;1-40 Australian Society for Microbiology, Melbourne.
55. Martin D.R. Rheumatogenic and nephritogenic group A streptococci. Myth or reality? Adv Exp Med Biol. 418:1997;21-27.
56. Pruksakorn S., Sittisombut N., Phornphutkul C., Pruksachatkunakorn C., Good M.F., Brandt E. Epidemiological analysis of non-M-typeable group A streptococcus isolates from a Thai population in northern Thailand. J Clin Microbiol. 38:2000;1250-1254.
57. Bessen D.E., Carapetis J.R., Beall B., et al. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis. 182:2000;1109-1116.
58. McGregor KF, Bilek N, Bennett A, et al. Group A streptococci from a remote community have novel multilocus genotypes but share emm-types and housekeeping alleles with isolates from worldwide sources. J Infect Dis; in press.
59. Banks D.J., Beres S.B., Musser J.M. The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol. 10:2002;515-521.
60. Bisno A.L., Brito M.O., Collins C.M. Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 3:2003;191-200.
61. Cunningham M.W. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci. 8:2003;S533-543.
62. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 13:2000;470-511.
63. Figueroa F., Gonzalez M., Carrion F., et al. Restriction in the usage of variable beta regions in T-cells infiltrating valvular tissue from rheumatic heart disease patients. J Autoimmun. 19:2002;233-240.
64. Haidan A., Talay S.R., Rohde M., Sriprakash K.S., Currie B.J., Chhatwal G.S. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet. 356:2000;1167-1169.
65. Reid H., Bassett D., Poon-King T., Zabriskie J., Read S. Group G streptococci in healthy school-children and in patients with glomerulonephritis in Trinidad. J Hyg Camb. 94:1985;61-68.
66. Al-Sekait M., Al-Sweliem A., Tahir M. Rheumatic heart disease in schoolchildren in Western District, Saudi Arabia. J R Soc Health. 1:1990;15-16.
67. Bassili A., Barakat S., Sawaf G.E., Zaher S., Zaki A., Din Saleh E.E. Identification of clinical criteria for group A-beta hemolytic streptococcal pharyngitis in children living in a rheumatic fever endemic area. J Trop Pediatr. 48:2002;285-293.
68. Jansen T.L., Janssen M., de Jong A.J. Reactive arthritis associated with group C and group G beta-hemolytic streptococci. J Rheumatol. 25:1998;1126-1130.
69. Barnham M., Thornton T., Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet. 1:1983;945-947.
70. Bisno A., Collins C., Turner J. M proteins of group C streptococci isolated from patients with acute pharyngitis. J Clin Microbiol. 34:1996;2511-2515.
71. Kalia A., Bessen D.E. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol Lett. 219:2003;291-295.
72. Gordis L. Effectiveness of comprehensive care programs in preventing rheumatic fever. N Engl J Med. 289:1973;331-335.
73. Danchin M.H., Curtis N., Nolan T.M., Carapetis J.R. Treatment of sore throat in light of the Cochrane verdict: is the jury still out? Med J Aust. 177:2002;512-515.
74. Veasy L., Wiedmeier S., Orsmond G., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 316:1987;421-427.
75. Steinhoff M., El Khalek M., Khallaf N., et al. Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children. Lancet. 350:1997;918-921.
76. Atha M., Enos E., Frank C., et al. How an American Indian tribe controlled the streptococcus. World Health Forum. 3:1982;423-428.
77. Bach J., Chalons S., Forier E., et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet. 347:1996;644-648.
78. Hanna J., O'Rourke S. Rheumatic fever and chronic rheumatic heart disease in Yarrabah Aboriginal community, north Queensland. Med J Aust. 158:1993;793.
79. Anonymous. Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ 1995; 73: 583-587.
80. Wong L.C., Amega B., Barker R., et al. Factors supporting sustainability of a community-based scabies control program. Australas J Dermatol. 43:2002;274-277.
81. Taplin D., Porcelain S., Meinking T., et al. Community control of scabies: a model based on use of permethrin cream. Lancet. 337:1991;1016-1018.
82. Good M.F. Progress towards developing a vaccine for group A streptococcus based on the M protein. Intern Med J. 32:2002;132-213.